Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Debt / NOTE 2.250% 4/0
-
Market price (% of par)
-
111.5%
-
Total 13F principal
-
$569,471,000
-
Principal change
-
+$17,187,425
-
Total reported market value
-
$635,090,756
-
Number of holders
-
37
-
Value change
-
+$11,704,865
-
Number of buys
-
22
-
Number of sells
-
17
Institutional Holders of ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 as of Q2 2024
As of 30 Jun 2024,
ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 was held by
37 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$569,471,000
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, FRANKLIN RESOURCES INC, READYSTATE ASSET MANAGEMENT LP, Balyasny Asset Management L.P., AVIVA PLC, Davidson Kempner Capital Management LP, PFM Health Sciences, LP, LAZARD ASSET MANAGEMENT LLC, and Point72 Asset Management, L.P..
This page lists
37
institutional bondholders reporting positions
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.